How much does ibrutinib cost?

Ibrutinib (Ibrutinib) is an oral anti-cancer drug that belongs to a class of drugs called "BTK inhibitors". BTK stands for "Bruton's tyrosine kinase" , a protein that plays a key role in B lymphocytes. Ibrutinib prevents the growth and division of B lymphocytes by inhibiting the activity of BTK

1.Chronic lymphocytic leukemia (CLL): Ibrutinib is commonly used to treat adult patients with chronic lymphocytic leukemia, particularly those who have received at least one other treatment that has failed to effectively control the disease.

2.Small lymphocytic lymphoma (SLL): Ibrutinib can also be used to treat small lymphocytic lymphoma, a related disease that often coexists with CLL.

3.Mucosa-associated lymphoid tissue lymphoma (MALTlymphoma): Ibrutinib is also used to treat certain other specific subtypes of Bcell lymphoma, including mucosa-associated lymphoid tissue lymphoma.

Ibrutinib is currently on the market in China and is included in medical insurance. The domestic price ranges from 10,000 to 20,000. Due to different medical insurance policies in different places, the price is also different. For specific reimbursement information, please consult the local hospital pharmacy or medical insurance bureau. The cheaper types of ibrutinib abroad are generic drugs, mainly Indian generic drugs, Bangladeshi generic drugs and Laotian generic drugs, with prices ranging from a few hundred to several thousand yuan. AndThe ingredients of generic ibrutinib and domestic ibrutinib are basically the same.